To understand where GHRP-6 resides in physiology, you need to see that the pituitary gland receives the “secrete growth hormone” signal through more than one channel. The somatotropic cell of the anterior pituitary has at least two separate receptors on its surface that stimulate GH release: GHRH receptor (growth hormone releasing hormone) and growth hormone secretion receptor type 1a (GHS-R1a), i.e. ghrelin receptor.
These are two different proteins, two different intracellular cascades and two different physiological signals – which converge on the same end result, the release of GH from secretory granules. GHRP-6 acts on the second of these channels – the ghrelin arm.
Growth hormone is not secreted in a flat, steady stream – the pituitary gland releases GH impulses, in pulses of a specific amplitude and frequency, regulated by a pair of opposing signals from the hypothalamus. GHRH tells the pituitary “secrete”, somatostatin says “hold”. There is a third player on top of this system – ghrelin and its receptor GHS-R1a – which acts as a separate, complementary switch for GH release and, importantly for GHRP-6, suppresses somatostatin (takes off the brake) and enhances its own GHRH effect.
The pharmacology of GH-releasing peptides arises precisely from the question: what happens when we stimulate this third channel separately? The pulsatile nature of GH secretion is the main physiological detail here.
Unlike exogenous, recombinant growth hormone, which floods the circulation with a flat, nonphysiological concentration, secretagogues stimulate own pituitary to release GH in a way that preserves the pulsatile signal architecture – involving the somatostatin feedback loop. This “endogenous, pulsatile” release pattern is the subject of research into the physiology of the GH/IGF-1 axis. The pharmacology of growth hormone secretagogues includes two large classes of tools:
- GHRH analogues — imitate the endogenous GH-releasing hormone, stimulate the GHRH receptor, increase the pulse amplitude (CJC-1295 with DAC, sermorelin, tesamorelin)
- GH-releasing peptides (GHRP) and ghrelin mimetics — stimulate the GHS-R1a ghrelin receptor, increase the pulse rate and suppress somatostatin (GHRP-6, GHRP-2, hexarelin, Ipamorelin)
GHRP-6 is historical prototype second class – the peptide on which this class is defined. It is also its most orexigenic representative: among the classic GHRPs, GHRP-6 stimulates appetite most strongly by activating ghrelin in the hypothalamus, which makes it a model tool not only for studying the GH axis, but also for studying ghrelin as an appetite regulator.